These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia]. Yago K; Itoh M; Shimada H Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079 [TBL] [Abstract][Full Text] [Related]
7. Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes. Hong R; Shen V; Rooney C; Hughes DP; Smith C; Comoli P; Zhang L Clin Immunol; 2001 Jan; 98(1):54-61. PubMed ID: 11141327 [TBL] [Abstract][Full Text] [Related]
8. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783 [TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse. Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478 [TBL] [Abstract][Full Text] [Related]
10. A case of a long-time survivor with chronic active Epstein-Barr virus infection. Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269 [TBL] [Abstract][Full Text] [Related]
11. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Kuzushima K; Yamamoto M; Kimura H; Ando Y; Kudo T; Tsuge I; Morishima T Clin Exp Immunol; 1996 Feb; 103(2):192-8. PubMed ID: 8565299 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients. Sato T; Fujieda M; Maeda A; Tanaka E; Miyamura M; Chikamoto H; Hisano M; Akioka Y; Ishiura Y; Dohno S; Hattori M; Wakiguchi H Clin Nephrol; 2008 Nov; 70(5):393-403. PubMed ID: 19000539 [TBL] [Abstract][Full Text] [Related]
13. [Virus-specific cytotoxic T cells in chronic active Epstein-Barr virus infection]. Shibayama H; Imadome KI; Onozawa E; Tsuzura A; Miura O; Koyama T; Arai A Rinsho Ketsueki; 2017; 58(6):583-588. PubMed ID: 28679986 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535 [TBL] [Abstract][Full Text] [Related]
16. Experience with cultured thymus tissue in 105 children. Markert ML; Gupton SE; McCarthy EA J Allergy Clin Immunol; 2022 Feb; 149(2):747-757. PubMed ID: 34362576 [TBL] [Abstract][Full Text] [Related]
17. Combined microdeletions and CHD7 mutation causing severe CHARGE/DiGeorge syndrome: clinical presentation and molecular investigation by array-CGH. Kaliakatsos M; Giannakopoulos A; Fryssira H; Kanariou M; Skiathitou AV; Siahanidou T; Giannikou K; Makrythanasis P; Kanavakis E; Tzetis M J Hum Genet; 2010 Nov; 55(11):761-3. PubMed ID: 20686492 [TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation. Zhou L; Lu DP Virol J; 2019 Feb; 16(1):19. PubMed ID: 30736814 [TBL] [Abstract][Full Text] [Related]
19. Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning. Li Q; Rane L; Poiret T; Zou J; Magalhaes I; Ahmed R; Du Z; Vudattu N; Meng Q; Gustafsson-Jernberg Å; Winiarski J; Ringdén O; Maeurer M; Remberger M; Ernberg I Oncotarget; 2016 May; 7(21):30230-40. PubMed ID: 27102298 [TBL] [Abstract][Full Text] [Related]
20. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]